| Financial Year |
March 31 2022 |
| Monetary Funds |
187,185,830.84 |
| Held-for-trading Financial Assets |
101,507,835.61 |
| Notes Receivable |
15,890,175.51 |
| Accounts Receivable |
143,179,766.92 |
| Advances to Suppliers |
20,477,266.09 |
| Other Receivables |
17,206,291.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
195,835,453.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,252,728.05 |
| Total Current Assets |
730,609,894.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
78,595,559.31 |
| Fixed Assetes |
359,302,308.81 |
| Under-construction Projects |
291,629,795.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,492,655.64 |
| R&D expenses |
12,118,773.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,007,649.42 |
| Deferred Income Tax Assets |
69,685,463.28 |
| Other Non-Current Assets |
3,581,776.00 |
| Sub-Total of Non-Current Assets |
926,171,599.74 |
| Total Assets |
1,656,781,494.57 |
| Short-Term Loans |
86,988,146.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,252,259.14 |
| Accounts Payable |
59,358,158.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,699,798.44 |
| Taxes Payable |
3,943,214.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,133,153.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,045,911.91 |
| Other Current Liabilities |
4,716,440.16 |
| Sub-Total of Current Liabilities |
272,468,325.28 |
| Long-term Loans |
192,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,603,594.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
252,149,111.20 |
| Total Liabilities |
524,617,436.48 |
| Paid-In Capital(Or Share Stock) |
247,806,170.00 |
| Capital Surplus |
641,827,191.20 |
| Surplus Reserve |
73,841,867.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
168,140,574.72 |
| Minority Stockholder's Interest |
590,986.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,131,573,071.77 |
| Owner's Equity（Stockholder's Equity） |
1,132,164,058.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,656,781,494.57 |
